Mersana Therapeutics to Host Conference Call and Webcast to Discuss the Selection of the NaPi2b Biomarker Cutoff and Commercial Diagnostic Development PathGlobeNewsWire • 04/09/21
Mersana Therapeutics Announces Initiation of UPLIFT Single-Arm Registration Strategy for UpRi in Platinum-Resistant Ovarian CancerGlobeNewsWire • 04/09/21
Mersana Therapeutics Announces Publication of Two Manuscripts Detailing Preclinical Studies of the Dolaflexin Platform and Upifitamab Rilsodotin (XMT-1536) in AACR Journal Molecular Cancer TherapeuticsGlobeNewsWire • 03/15/21
Mersana Therapeutics to Present Three Posters at Upcoming Virtual 2021 American Association for Cancer Research Annual MeetingGlobeNewsWire • 03/10/21
Mersana Therapeutics, Inc.'s (MRSN) CEO Anna Protopapas on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 02/26/21
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2020 Financial Results and Business UpdatesGlobeNewsWire • 02/19/21
Mersana Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare ConferenceGlobeNewsWire • 02/17/21
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech ActivityBenzinga • 01/16/21
Mersana Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/21
Mersana Therapeutics Announces Corporate and Pipeline Updates and 2021 Goals and Anticipated MilestonesGlobeNewsWire • 01/05/21
Mersana Therapeutics Reports Preclinical Data from Immunosynthen STING-Agonist ADC Platform and PipelineGlobeNewsWire • 11/11/20
Mersana Therapeutics' (MRSN) CEO Anna Protopapas on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Mersana Therapeutics to Host Webinar Highlighting Immunosynthen STING-Agonist ADC Platform and PipelineGlobeNewsWire • 11/09/20
Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/09/20
Mersana Therapeutics to Present at 29th Annual Credit Suisse Virtual Healthcare ConferenceGlobeNewsWire • 11/04/20
Mersana Therapeutics to Host Conference Call Announcing Third Quarter 2020 Financial Results and Business UpdatesGlobeNewsWire • 11/02/20